Table 4. The 4 predominant patterns in drug-resistant culture positive TB cases with DST results, by country of birth and age group (for cases with available information), Germany 2008–2017, Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E), and Streptomycin (S).
Age group: < 15 yr. | ||||||
Country of birth | Total No. of TB cases | Any resistance present | Among any resistance | |||
H | Z | S | HS | |||
Germany | 366 | 64 (17.5%) | 16 (25.0%) | 6 (9.4%) | 20 (31.3%) | 12 (18.8%) |
Other | 209 | 39 (18.7%) | 9 (23.1%) | 6 (15.4%) | 7 (17.9%) | 5 (12.8%) |
Total | 575 | 103 (17.9%) | 25 (24.3%) | 12 (11.7%) | 27 (26.2%) | 17 (16.5%) |
Age group: 15–39 yr. | ||||||
Total No. of TB cases | Any resistance present | Among any resistance | ||||
H | Z | S | HS | |||
Germany | 1,979 | 167 (8.4%) | 50 (29.9%) | 10 (6.0%) | 54 (32.3%) | 24 (14.4%) |
Other | 8,323 | 1,381 (16.6%) | 302 (21.9%) | 101 (7.3%) | 354 (25.6%) | 218 (15.8%) |
Total | 10,302 | 1,548 (15.0%) | 352 (22.7%) | 111 (7.2%) | 408 (26.4%) | 242 (15.6%) |
Age group: 40–59 yr. | ||||||
Total No. of TB cases | Any resistance present | Among any resistance | ||||
H | Z | S | HS | |||
Germany | 3,449 | 287 (8.3%) | 71 (24.7%) | 45 (15.7%) | 76 (26.5%) | 45 (15.7%) |
Other | 3,542 | 633 (17.9%) | 132 (20.9%) | 46 (7.3%) | 139 (22.0%) | 150 (23.7%) |
Total | 6,991 | 920 (13.2%) | 203 (22.1%) | 91 (9.9%) | 215 (23.4%) | 195 (21.2%) |
Age group: 60+ yr. | ||||||
Total No. of TB cases | Any resistance present | Among any resistance | ||||
H | Z | S | HS | |||
Germany | 5,174 | 395 (7.6%) | 91 (23.0%) | 145 (36.7%) | 86 (21.8%) | 18 (4.6%) |
Other | 2,525 | 283 (11.2%) | 78 (27.6%) | 44 (15.5%) | 61 (21.6%) | 56 (19.8%) |
Total | 7,699 | 678 (8.8%) | 169 (24.9%) | 189 (27.9%) | 147 (21.7%) | 74 (10.9%) |
All age groups | ||||||
Total No. of TB cases | Any resistance present | Among any resistance | ||||
H | Z | S | HS | |||
Germany | 10,969 | 913 (8.3%) | 228 (24.9%) | 206 (22.6%) | 236 (25.8%) | 99 (10.8%) |
Other | 14,600 | 2,336 (16.0%) | 521 (22.3%) | 197 (8.4%) | 561 (24.0%) | 429 (18.4%) |
Total | 25,569 | 3,249 (12.7%) | 749 (23.1%) | 403 (12.4%) | 797 (24.5%) | 528 (16.3%) |